Font:
AJ

AJANTPHARM / NSE / Biotechnology & Drugs

Ajanta Pharma

INR 3,348.6-102.90 (1.65%) 1D
Last updated: 2026-07-17T07:21:34.509378+00:00
Price Chart

1Y Price Trend

Open2,800
High3,506.9
Low2,329.9
Close3,425.2
Volume49,270
Change625.2
Change %22.33%

Key Information

Ticker SymbolAJANTPHARM
Current Price3,348.6
52-Week High3,506.9
52-Week Low2,329.9
Market Cap41,915
Beta0.65
Volume49,270
ISININE031B01049
Day High3,454
Day Low3,341.1
Open3,454

Recommendations

RatingStrong Buy

Target High3,505.55

Target Low2,335

Target Mean1.73

Target Median91.67

Risk Metrics

Overall RiskBalanced risk

Board Risk28.67

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

FAQ

Stock FAQs

What is the symbol and ISIN of Ajanta Pharma?

Ajanta Pharma has the symbol AJANTPHARM and ISIN - INE031B01049.

What is the current price of Ajanta Pharma?

Ajanta Pharma is currently trading at INR 3,348.60.

What are the year high and year low of Ajanta Pharma?

Ajanta Pharma has a year high of INR 3,505.55 and a year low of INR 2,335.00.

What is the market capitalization of Ajanta Pharma?

Ajanta Pharma has a market capitalization of INR 41,915.00 crore.

What is the P/E ratio of Ajanta Pharma?

Ajanta Pharma has a P/E ratio of 33.19.

What is the dividend yield of Ajanta Pharma?

Ajanta Pharma has a dividend yield of 0.85%.

How is the financial performance of Ajanta Pharma based on revenue, net income, and EPS?

Ajanta Pharma has revenue of INR 54,528.60 crore, net income of INR 10,560.00 crore, and EPS of INR 84.51.

What is the book value of Ajanta Pharma?

Ajanta Pharma has a book value of INR 359.03.

What is the debt-to-equity ratio of Ajanta Pharma?

Ajanta Pharma has a debt-to-equity ratio of NA.

What are the price-to-book and price-to-sales ratios of Ajanta Pharma?

Ajanta Pharma has a price-to-book ratio of 9.33 and a price-to-sales ratio of 0.77.